Trial
NCT01079793
Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Texas Southwestern Medical Center
Collaborators
National Cancer Institute (NCI)
Condition
Prostate Cancer
Intervention
ixabepilone
Why stopped
Overlapping study, PI preferred to enroll in alternate trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-08-20